Most Recent
A former head of medical at Sanofi-Aventis has sued the Australian branch of the pharmaceutical giant, claiming he was unfairly dismissed in a "'sham redundancy” and faced discrimination because of his age and disabilities.
Grant Thornton can't dodge a “significant” counterclaim accusing the accounting firm of charging for “unnecessary and pointless" work in a case against a former client over $119,000 in unpaid fees.
If evidence were needed that courts are not rubber stamping class action settlements, the scrutiny of multi-million dollar agreements in 2021 is proof positive that judicial oversight of representative proceedings is robust.
Energy retailer CovaU has been hit with $33,300 in penalties by the Australian Competition and Consumer Commission over its alleged failure to provide consumers with a percentage price comparison for its residential electricity plans.
US-based telecommunications giant Verizon has sued a Melbourne company for allegedly violating its 'Verizon' trade marks by registered a business with the same name.
Accounting giant KPMG is seeking the dismissal of a lawsuit brought by a former long-serving employee over “unnecessarily aggressive, belittling and disproportionate” emails allegedly attacking his professional integrity.
Mylan's Australia unit is appealing decisions by the tax office to refuse deductions on interest paid under loans taken out by the pharmaceutical giant to help fund the $1.2 billion acquisition of generic drug maker Alphapharm almost 15 years ago.
Technology giant Lenovo has been accused of taking adverse action against a compliance manager who complained of workplace bullying and harassment.
HarperCollins has agreed to settle a defamation lawsuit by Russian oligarch Roman Abramovich, with the publisher promising to amend significant portions of its best-selling book chronicling the rise of Russian President Vladimir Putin.
Bayer has lost its bid to redact the names and contact details of potential group members from discovered documents in a Slater & Gordon-led class action over the drug maker's Essure contraceptive device.